DEVELOPMENT OF ANTIVIRALS FOR SPECIFIC RNA VIRAL FAMILIES OF PANDEMIC POTENTIAL
DEVELOPMENT OF ANTIVIRALS FOR SPECIFIC RNA VIRAL FAMILIES OF PANDEMIC POTENTIAL
批准号:
10933177
负责人:
GREG HENKEL
金额:
$369.2万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-09-22 至 2025-12-31
关键词:
Advanced DevelopmentChemistryClinicalDevelopmentFamilyLassa virusPathway interactionsRNAViralVirusantiviral drug developmentefficacy evaluationmanufacturepandemic diseasepandemic potentialpre-clinicalproduct developmentprogramsresearch and developmentsafety assessmenttherapeutic candidatetherapeutic development
中文摘要
支持对大流行抗病毒计划中有大流行潜力的病毒进行有前途的候选治疗药物的高级开发。支持的研发活动将允许候选治疗产品通过产品开发途径取得进展,包括临床前和IND开发活动,化学优化/开发,GMP制造以及临床安全性和有效性评估。
英文摘要
To support the advanced development of a promising candidate therapeutic for a virus with pandemic potential included under the Antiviral Program for Pandemics. The research and development activities to be supported will allow the candidate therapeutic product to progress through the product development pathway, and include preclinical and IND enabling development activities, chemistry optimization/development, GMP manufacturing, and clinical safety and efficacy assessment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
FUNCTION OF THE TRANSCRIPTION FACTOR PU1
-
批准号:2671608
-
项目类别:
-
资助金额:$3.18万
-
财政年份:1998
-
负责人:GREG HENKEL
-
依托单位:
FUNCTION OF THE TRANSCRIPTION FACTOR PU1
-
批准号:2059389
-
项目类别:
-
资助金额:$2.86万
-
财政年份:1997
-
负责人:GREG HENKEL
-
依托单位:
FUNCTION OF THE TRANSCRIPTION FACTOR PU1
-
批准号:2457669
-
项目类别:
-
资助金额:$2.99万
-
财政年份:1997
-
负责人:GREG HENKEL
-
依托单位:
国内基金
海外基金
SCIENCE CHINA Chemistry
-
批准号:21224001
-
项目类别:专项基金项目
-
资助金额:24.0万元
-
批准年份:2012
-
负责人:朱晓文
-
依托单位:
Science China Chemistry
-
批准号:21024801
-
项目类别:专项基金项目
-
资助金额:24.0万元
-
批准年份:2010
-
负责人:朱晓文
-
依托单位:
运用Linkage Chemistry合成新型聚合物缀合物和刷形共聚物
-
批准号:20974058
-
项目类别:面上项目
-
资助金额:12.0万元
-
批准年份:2009
-
负责人:袁金颖
-
依托单位: